Metraipolis › archive › dc_6ef9bc281f55
Atractylenolide III for central nervous system disorders: a review of multi-target mechanisms and therapeutic potential — Europe PMC PMID:42292848
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42292848
- DOI
- 10.3389/fphar.2026.1799976
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T04:07:35.889Z
- SHA-256 of the archived text
68f0cc274b0d8720fbf8e18a057f90f5b9ec3364aedb54839e538ac84769a71d- Stable URL of this page
https://metraipolis.com/documento/dc_6ef9bc281f55
How to cite
Atractylenolide III for central nervous system disorders: a review of multi-target mechanisms and therapeutic potential — Europe PMC PMID:42292848 — Europe PMC (en), https://europepmc.org/article/MED/42292848 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ef9bc281f55 (Metraipolis archive dc_6ef9bc281f55, sha256 68f0cc274b0d8720fbf8e18a057f90f5b9ec3364aedb54839e538ac84769a71d)
BibTeX
@misc{dc6ef9bc281f55,
title = {Atractylenolide III for central nervous system disorders: a review of multi-target mechanisms and therapeutic potential — Europe PMC PMID:42292848},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42292848},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ef9bc281f55; sha256 68f0cc274b0d8720fbf8e18a057f90f5b9ec3364aedb54839e538ac84769a71d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292848. Agents can read the archived copy with the MCP tool read_document.